Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,138 | 64 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $255.46 | 16 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $202.62 | 12 | $0 (2021) |
| Amgen Inc. | $109.95 | 7 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $98.07 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $77.79 | 5 | $0 (2022) |
| GlaxoSmithKline, LLC. | $69.42 | 5 | $0 (2018) |
| Lupin Inc. | $58.47 | 3 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $57.02 | 4 | $0 (2021) |
| Exact Sciences Corporation | $46.15 | 2 | $0 (2023) |
| Lilly USA, LLC | $43.14 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.35 | 1 | AstraZeneca Pharmaceuticals LP ($14.35) |
| 2023 | $97.51 | 4 | Exact Sciences Corporation ($46.15) |
| 2022 | $26.67 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($26.67) |
| 2021 | $88.38 | 5 | Janssen Pharmaceuticals, Inc ($38.85) |
| 2020 | $152.64 | 10 | Janssen Pharmaceuticals, Inc ($71.42) |
| 2019 | $334.23 | 19 | Novo Nordisk Inc ($144.20) |
| 2018 | $175.38 | 12 | Amgen Inc. ($48.66) |
| 2017 | $248.94 | 12 | AMAG Pharmaceuticals, Inc. ($98.07) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/06/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/01/2018 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Endocrinology | ||||||
| 11/20/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 11/14/2017 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $98.07 | General |
| Category: INTRAROSA | ||||||
| 11/13/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2017 | Novo Nordisk Inc | Victoza (Drug), Xultophy 100/3.6, Tresiba | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Diabetes | ||||||
| 10/16/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2017 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.11 | General |
| 08/15/2017 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Endocrinology | ||||||
| 06/05/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Diabetes | ||||||
| 05/31/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO (Drug) | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2017 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 23 | 23 | $2,756 | $992.84 |
| 2022 | 1 | 11 | 13 | $2,160 | $1,216 |
| 2021 | 1 | 11 | 11 | $1,419 | $470.14 |
| 2020 | 2 | 22 | 25 | $3,560 | $1,502 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 12 | 12 | $1,436 | $502.68 | 35.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 11 | 11 | $1,320 | $490.16 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $2,160 | $1,216 | 56.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 11 | 11 | $1,419 | $470.14 | 33.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 14 | $2,240 | $1,014 | 45.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 11 | 11 | $1,320 | $487.96 | 37.0% |
About Dr. Mukundini Mehta, MD
Dr. Mukundini Mehta, MD is a Gynecology healthcare provider based in Cicero, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1154303584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mukundini Mehta, MD has received a total of $1,138 in payments from pharmaceutical and medical device companies, with $14.35 received in 2024. These payments were reported across 64 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,138).
As a Medicare-enrolled provider, Mehta has provided services to 67 Medicare beneficiaries, totaling 72 services with total Medicare billing of $4,181. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Other Specialties Obstetrics & Gynecology
- Location Cicero, IL
- Active Since 11/21/2005
- Last Updated 01/11/2024
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1154303584
Products in Payments
- XARELTO (Drug) $184.62
- Tresiba (Drug) $130.65
- INTRAROSA (Drug) $98.07
- Prolia (Biological) $78.11
- SOLOSEC (Drug) $58.47
- ADVAIR (Drug) $57.58
- Cologuard Collection Kit (Device) $46.15
- Ozempic (Drug) $42.55
- Victoza (Drug) $40.93
- TRINTELLIX (Drug) $37.91
- EVENITY (Biological) $31.84
- TRULICITY (Drug) $29.63
- SPIRIVA RESPIMAT (Drug) $26.84
- JARDIANCE (Drug) $26.67
- STIOLTO (Drug) $24.28
- ELIQUIS (Drug) $21.73
- FLUZONE HIGH-DOSE (Biological) $20.60
- Trintellix (Drug) $19.11
- INVOKANA (Drug) $18.00
- LINZESS (Drug) $17.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.